Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_35124 | 780 | 16.25 | Mlig455_059030, Mlig455_070853 | Neo: - Age: Down-Up-Down Region-enriched R6: 6.026/0.00025 |
Mlig455_059030 {REF} {Length: 944} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.7]; EF-hand domain pair [PF13499.8, score=25.4]; EF hand [PF00036.34, score=21.8]; EF-hand domain [PF14658.8, score=20.5]; EF-hand domain [PF13405.8, score=19.8]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=128, Expect=6e-38]} {RNA1509_37636} {RNA1310_36928, RNA1509_37636} {RNA1509_37636, RNA815_25288} Mlig455_070853 {REF} {Length: 962} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.8]; EF-hand domain pair [PF13499.8, score=25.6]; EF-hand domain [PF13405.8, score=21.1]; EF hand [PF00036.34, score=21.0]; EF-hand domain [PF14658.8, score=20.2]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=127, Expect=7e-38]} {RNA1509_37636} {RNA1310_36928} {RNA815_25288} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -0.677 | 4.33 | 0.98459 | 1.00000 | |
RegionR2 | 5.218 | 4.33 | 0.00151 | 0.02887 | |
RegionR3 | 0.175 | 4.33 | 0.67348 | 1.00000 | |
RegionR4 | -0.487 | 4.33 | 0.94320 | 1.00000 | |
RegionR5 | -1.272 | 4.33 | 0.98924 | 1.00000 | |
RegionR6 | 6.026 | 4.33 | 0.00000 | 0.00025 | |
RegionR7 | -2.44 | 4.33 | 0.99963 | 1.00000 | |
RegionR8 | -6.543 | 4.33 | 0.05304 | 0.44888 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -6.601 | 4.33 | 0.20065 | 0.94047 | |
RegenerationR2 | -3.202 | 4.33 | 0.02405 | 0.25525 | |
RegenerationR3 | -2.586 | 4.33 | 0.08664 | 0.47819 | |
RegenerationR4 | -3.476 | 4.33 | 0.02754 | 0.26639 | |
RegenerationR5 | -1.293 | 4.33 | 0.40742 | 0.80412 | |
RegenerationR6 | -4.884 | 4.33 | 0.00150 | 0.04333 | |
RegenerationBL | 2.318 | 4.33 | 0.17929 | 0.50811 | |
RegenerationTP | -2.456 | 4.33 | 1.00000 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_35124 | 780 | 16.25 | Mlig455_059030, Mlig455_070853 | Neo: - Age: Down-Up-Down Region-enriched R6: 6.026/0.00025 |
6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_059030 {REF} {Length: 944} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.7]; EF-hand domain pair [PF13499.8, score=25.4]; EF hand [PF00036.34, score=21.8]; EF-hand domain [PF14658.8, score=20.5]; EF-hand domain [PF13405.8, score=19.8]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=128, Expect=6e-38]} {RNA1509_37636} {RNA1310_36928, RNA1509_37636} {RNA1509_37636, RNA815_25288} Mlig455_070853 {REF} {Length: 962} {Pfam: Dynein light chain type 1 [PF01221.20, score=58.8]; EF-hand domain pair [PF13499.8, score=25.6]; EF-hand domain [PF13405.8, score=21.1]; EF hand [PF00036.34, score=21.0]; EF-hand domain [PF14658.8, score=20.2]} {Smed: dd_Smed_v6_6707_0_3, dd_Smed_v6_6707_0_3, [Score=127, Expect=7e-38]} {RNA1509_37636} {RNA1310_36928} {RNA815_25288} |
|
2. | MligTC455_52321 | 3915 | 81.56 | Mlig455_067358 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.038/0.00007 |
4.403 | - | 0.900 | 0.811 | 0.928 | 0.957 | 0.807 | Mlig455_067358 {REF} {Length: 974} {RNA1509_6241} {RNA1310_39514.1} {RNA815_19638} | |
3. | MligTC455_33814 | 559 | 11.65 | Mlig455_061944 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.446/0.00053 |
MOXD1 | 3.516 | - | 0.734 | 0.825 | 0.974 | 0.983 | - | Mlig455_061944 {REF} {Length: 2816} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=105.5]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=67.8]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=129, Expect=2e-31]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=141, Expect=1e-35]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=116, Expect=3e-27]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=129, Expect=9e-32]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=120, Expect=7e-30]} {RNA1509_41983} {RNA1310_8990, RNA1509_41983} {RNA1509_41983, RNA815_3230} |
4. | MligTC455_32615 | 24 | 0.5 | Mlig455_062450 | Neo: - Age: - |
ARX | 3.439 | - | - | 0.829 | 0.877 | 0.970 | 0.763 | Mlig455_062450 {REF} {Length: 1977} {Pfam: Homeodomain [PF00046.31, score=83.5]} {Human: ENSG00000004848, ARX, aristaless related homeobox, [RH, Score=134, Expect=1e-34]} {Mouse: ENSMUSG00000035277, Arx, aristaless related homeobox, [RH, Score=134, Expect=1e-34]} {Dmel: FBgn0000061, al, aristaless, [RH, Score=130, Expect=3e-34]} {Celegans: WBGene00044330, alr-1, AristaLess (Drosophila homeodomain) Related, [RH, Score=119, Expect=2e-30]} {Smed: dd_Smed_v6_63359_0_1, dd_Smed_v6_63359_0_1, [Score=117, Expect=2e-32]} {RNA1310_53718} {RNA815_48205} |
5. | MligTC455_23098 | 38 | 0.78 | Mlig455_019169 | Neo: - Age: - Region-enriched R2: 6.693/0.03013 |
NR2E3 | 3.429 | - | 0.786 | 0.730 | 0.921 | 0.992 | - | Mlig455_019169 {REF} {Length: 2731} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=97.7]; Ligand-binding domain of nuclear hormone receptor [PF00104.32, score=85.2]} {Human: ENSG00000278570, NR2E3, nuclear receptor subfamily 2 group E member 3, [RH, Score=220, Expect=3e-64]} {Mouse: ENSMUSG00000032292, Nr2e3, nuclear receptor subfamily 2, group E, member 3, [RH, Score=216, Expect=8e-63]} {Dmel: FBgn0034012, Hr51, Hormone receptor 51, [RH, Score=189, Expect=2e-51]} {Celegans: WBGene00001400, fax-1, Nuclear hormone receptor FAX-1, [RH, Score=179, Expect=1e-49]} {Smed: dd_Smed_v6_24412_0_1, dd_Smed_v6_24412_0_1, [RH, Score=196, Expect=3e-54]} {RNA1310_101745} |
6. | MligTC455_41628 | 140 | 2.91 | Mlig455_015910 | Neo: - Age: - |
RYK | 3.25 | - | 0.700 | 0.771 | 0.973 | 0.806 | - | Mlig455_015910 {REF} {Length: 2784} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=111.2]; WIF domain [PF02019.20, score=98.1]; Protein kinase domain [PF00069.27, score=37.2]; Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.3]} {Human: ENSG00000163785, RYK, receptor-like tyrosine kinase, [Score=135, Expect=3e-33]} {Mouse: ENSMUSG00000032547, Ryk, receptor-like tyrosine kinase, [Score=136, Expect=2e-33]} {Dmel: FBgn0033791, Drl-2, Derailed 2, [Score=195, Expect=2e-53]} {Celegans: WBGene00003007, lin-18, Inactive tyrosine-protein kinase RYK, [Score=116, Expect=4e-27]} {Smed: dd_Smed_v6_12594_0_2, dd_Smed_v6_12594_0_2, [Score=135, Expect=3e-33]} {RNA1310_8002.1} {RNA815_18265} |
7. | MligTC455_20016 | 607 | 12.65 | Mlig455_041914 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.404 Region-enriched R2: 5.008/0.00002 |
3.225 | 0.738 | - | 0.745 | 0.953 | 0.789 | - | Mlig455_041914 {REF} {Length: 745} {Pfam: EF-hand domain [PF13405.8, score=60.3]; EF hand [PF00036.34, score=52.6]; EF-hand domain pair [PF13499.8, score=49.5]; EF hand [PF13202.8, score=40.2]; EF-hand domain [PF14658.8, score=30.6]; EF-hand domain pair [PF13833.8, score=30.2]} {Dmel: FBgn0052103, CG32103, [Score=43.5, Expect=1e-05]} {Smed: dd_Smed_v6_16347_0_2, dd_Smed_v6_16347_0_2, [Score=67.8, Expect=1e-15]} {RNA1509_17125, RNA1509_40839} {RNA1310_56976, RNA1509_40839} {RNA1509_40839, RNA815_29327} | |
8. | MligTC455_43783 | 8 | 0.17 | Mlig455_018589 | Neo: - Age: - |
2.751 | - | - | 0.819 | 0.942 | 0.990 | - | Mlig455_018589 {REF} {Length: 1005} {Pfam: WSC domain [PF01822.21, score=54.3]} | |
9. | MligTC455_17644 | 182 | 3.8 | Mlig455_007930, Mlig455_008033 | Neo: - Age: - |
2.75 | - | 0.790 | - | 0.996 | 0.964 | - | Mlig455_007930 {REF} {Length: 2086} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.9]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=3e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} Mlig455_008033 {REF} {Length: 1974} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=20.6]} {Smed: dd_Smed_v6_25359_0_1, dd_Smed_v6_25359_0_1, [Score=66.2, Expect=4e-12]} {RNA1509_7841} {RNA1310_25567} {RNA815_6213} |
|
10. | MligTC455_31464 | 20 | 0.41 | Mlig455_057157 | Neo: - Age: - |
2.691 | - | - | 0.770 | 0.940 | 0.981 | - | Mlig455_057157 {REF} {Length: 1285} {Pfam: Methyltransferase FkbM domain [PF05050.14, score=38.2]} {Smed: dd_Smed_v6_13824_0_1, dd_Smed_v6_13824_0_1, [RH, Score=47.0, Expect=2e-07]} {RNA1509_6604} {RNA1310_12860.1} {RNA815_6128.1} | |
11. | MligTC455_40791 | 75 | 1.56 | Mlig455_013501 | Neo: - Age: - Region-enriched R2: 7.804/0.01222 |
2.673 | - | - | 0.719 | 0.991 | 0.963 | - | Mlig455_013501 {REF} {Length: 2310} {Pfam: WSC domain [PF01822.21, score=57.5]; F5/8 type C domain [PF00754.27, score=52.4]; Clip-domain serine protease homolog Scarface [PF18399.3, score=20.3]} {Smed: dd_Smed_v6_52492_0_1, dd_Smed_v6_52492_0_1, [Score=58.5, Expect=2e-10]} {RNA1509_16751} {RNA1310_14302.1} {RNA815_6113.1} | |
12. | MligTC455_33813 | 325 | 6.77 | Mlig455_009548 | Neo: - Age: - |
MOXD1 | 2.661 | - | 0.721 | - | 0.952 | 0.988 | - | Mlig455_009548 {REF} {Length: 2790} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=105.1]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=67.2]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=130, Expect=5e-31]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=142, Expect=3e-35]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=116, Expect=7e-27]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=129, Expect=2e-31]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=119, Expect=3e-29]} {RNA1509_41983} {RNA1310_8990} {RNA815_3230} |
13. | MligTC455_24070 | 770 | 16.04 | Mlig455_038826, Mlig455_038914 | Neo: - Age: Down-Up-Down |
2.659 | - | 0.787 | - | 0.965 | 0.907 | - | Mlig455_038826 {REF} {Length: 1863} {RNA1509_15528} {RNA1310_31818} {RNA815_10793} Mlig455_038914 {REF} {Length: 2695} {RNA1509_15528} {RNA1310_31818} {RNA815_10793} |
|
14. | MligTC455_48127 | 47 | 0.97 | Mlig455_037173 | Neo: - Age: - |
2.645 | - | - | 0.711 | 0.945 | 0.989 | - | Mlig455_037173 {REF} {Length: 1938} {RNA1310_42908} {RNA815_22744} | |
15. | MligTC455_23099 | 185 | 3.85 | Mlig455_048061 | Neo: - |
2.64 | - | - | - | 0.994 | 0.942 | 0.704 | Mlig455_048061 {REF} {Length: 713} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452} {RNA815_4585} | |
16. | MligTC455_23101 | 397 | 8.28 | Mlig455_048080 | Neo: - Age: - Region-enriched R2: 3.122/0.00807 |
2.614 | - | - | 0.725 | 0.960 | 0.929 | - | Mlig455_048080 {REF} {Length: 721} {TRANSSPLICED} {RNA1509_16955} {RNA1310_49452, RNA1509_16955} {RNA1509_16955, RNA815_4585} | |
17. | MligTC455_46924 | 1562 | 32.53 | Mlig455_042561 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.240 Region-enriched R2: 5.226/0.00021 |
PI16 | 2.602 | 0.809 | - | - | 0.836 | 0.957 | - | Mlig455_042561 {REF} {Length: 1929} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=59.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=75.5, Expect=4e-14]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=78.6, Expect=3e-15]; ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=75.1, Expect=5e-15]} {Dmel: FBgn0038126, CG8483, [Score=65.9, Expect=2e-11]} {Celegans: WBGene00003055, lon-1, LONg, [Score=65.9, Expect=7e-12]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=140, Expect=2e-36]} {RNA1509_33691, RNA1509_4403} {RNA1310_19427.1, RNA1509_33691, RNA1509_4403} {RNA1509_33691, RNA1509_4403, RNA815_7689.1} |
18. | MligTC455_27786 | 197 | 4.11 | Mlig455_001303 | Neo: - Age: Up-Down-Down Region-specific R2: 6.990 Region-enriched R2: 6.421/0.02381 |
HMCN2 | 2.592 | - | - | 0.707 | 0.981 | 0.904 | - | Mlig455_001303 {REF} {Length: 2154} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.5]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=5e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_4579} {RNA1310_19586} {RNA815_17693} |
19. | MligTC455_48128 | 18 | 0.37 | Mlig455_052326 | Neo: - Age: - |
2.587 | - | - | 0.817 | 0.781 | 0.989 | - | Mlig455_052326 {REF} {Length: 3582} {RNA1310_42908} {RNA815_22744} | |
20. | MligTC455_17175 | 78 | 1.62 | Mlig455_042330, Mlig455_047110 | Neo: - Age: - |
GABRA6 | 2.582 | - | 0.700 | - | 0.928 | 0.954 | - | Mlig455_042330 {REF} {Length: 1845} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=115.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=104.1]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=236, Expect=1e-72]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=229, Expect=4e-69]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=241, Expect=9e-75]} {Dmel: FBgn0030707, CG8916, [Score=248, Expect=4e-77]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=227, Expect=2e-69]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=242, Expect=6e-76]} {RNA1310_60750} {RNA815_41846} Mlig455_047110 {REF} {Length: 1843} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=138.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=103.4]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [Score=248, Expect=4e-76]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [Score=246, Expect=4e-74]; ENSG00000151834, GABRA2, gamma-aminobutyric acid type A receptor alpha2 subunit, [Score=243, Expect=4e-74]; ENSG00000186297, GABRA5, gamma-aminobutyric acid type A receptor alpha5 subunit, [Score=242, Expect=1e-73]; ENSG00000011677, GABRA3, gamma-aminobutyric acid type A receptor alpha3 subunit, [Score=239, Expect=3e-72]; ENSG00000022355, GABRA1, gamma-aminobutyric acid type A receptor alpha1 subunit, [Score=239, Expect=2e-72]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=236, Expect=2e-71]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [Score=254, Expect=1e-78]; ENSMUSG00000029211, Gabra4, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 4, [Score=244, Expect=1e-73]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [Score=244, Expect=1e-74]; ENSMUSG00000000560, Gabra2, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2, [Score=243, Expect=4e-74]} {Dmel: FBgn0030707, CG8916, [Score=268, Expect=2e-83]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [Score=252, Expect=1e-77]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [Score=263, Expect=1e-82]} {RNA1310_60750} {RNA815_41846} |
21. | MligTC455_54106 | 87 | 1.81 | Mlig455_046338, Mlig455_068234 | Neo: Int S/G2/M Age: Up-Down-Down |
PLCB1, PLCB3 | 2.568 | - | - | 0.764 | 0.816 | 0.988 | - | Mlig455_046338 {REF} {Length: 4577} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.8]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=69.3]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.5]} {Human: ENSG00000182621, PLCB1, phospholipase C beta 1, [Score=797, Expect=0.0]; ENSG00000149782, PLCB3, phospholipase C beta 3, [Score=796, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [Score=801, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [Score=784, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=418, Expect=4e-125]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=671, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_1, dd_Smed_v6_3221_0_1, [Score=702, Expect=0.0]} {RNA1509_50989} {RNA1310_17477} {RNA815_25811} Mlig455_068234 {REF} {Length: 4646} {Pfam: Phosphatidylinositol-specific phospholipase C, X domain [PF00388.21, score=201.7]; Phosphatidylinositol-specific phospholipase C, Y domain [PF00387.21, score=127.9]; PH domain [PF17787.3, score=123.2]; Protein of unknown function (DUF1154) [PF06631.13, score=28.5]; Phosphoinositide-specific phospholipase C, efhand-like [PF09279.13, score=27.4]} {Human: ENSG00000149782, PLCB3, phospholipase C beta 3, [RH, Score=837, Expect=0.0]; ENSG00000182621, PLCB1, phospholipase C beta 1, [RH, Score=831, Expect=0.0]} {Mouse: ENSMUSG00000051177, Plcb1, phospholipase C, beta 1, [RH, Score=830, Expect=0.0]; ENSMUSG00000024960, Plcb3, phospholipase C, beta 3, [RH, Score=827, Expect=0.0]} {Dmel: FBgn0004611, Plc21C, Phospholipase C at 21C, [Score=444, Expect=7e-134]} {Celegans: WBGene00001177, egl-8, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta egl-8, [Score=684, Expect=0.0]} {Smed: dd_Smed_v6_3221_0_2, dd_Smed_v6_3221_0_2, [Score=716, Expect=0.0]} {RNA1509_50989} {RNA1310_17477, RNA1509_50989} {RNA1509_50989, RNA815_25811} |
22. | MligTC455_19252 | 1355 | 28.24 | Mlig455_054908, Mlig455_065614, Mlig455_065623 | Neo: - Age: Down-Down-Up Region-enriched R2: 4.927/0.00706 |
QPCT | 2.545 | - | - | 0.705 | - | 0.990 | 0.850 | Mlig455_054908 {REF} {Length: 1427} {Pfam: Peptidase family M28 [PF04389.19, score=84.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=113, Expect=3e-28]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=123, Expect=8e-32]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=116, Expect=7e-30]} {Celegans: WBGene00010418, H27A22.1, [Score=124, Expect=6e-33]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=118, Expect=1e-30]} {RNA1509_35784} {RNA1310_28475} Mlig455_065614 {REF} {Length: 1515} {Pfam: Peptidase family M28 [PF04389.19, score=121.0]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=157, Expect=2e-44]} {Mouse: ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=162, Expect=2e-46]; ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=161, Expect=6e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=158, Expect=2e-45]} {Celegans: WBGene00010418, H27A22.1, [Score=166, Expect=2e-48]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=156, Expect=2e-44]} {RNA1509_35784} {RNA1310_28475, RNA1509_35784} Mlig455_065623 {REF} {Length: 1295} {Pfam: Peptidase family M28 [PF04389.19, score=121.4]} {Human: ENSG00000115828, QPCT, glutaminyl-peptide cyclotransferase, [Score=158, Expect=6e-45]} {Mouse: ENSMUSG00000030407, Qpctl, glutaminyl-peptide cyclotransferase-like, [Score=162, Expect=2e-46]; ENSMUSG00000024084, Qpct, glutaminyl-peptide cyclotransferase (glutaminyl cyclase), [Score=161, Expect=3e-46]} {Dmel: FBgn0052412, QC, Glutaminyl cyclase, [Score=154, Expect=8e-44]} {Celegans: WBGene00010418, H27A22.1, [Score=163, Expect=2e-47]} {Smed: dd_Smed_v6_4861_0_1, dd_Smed_v6_4861_0_1, [Score=154, Expect=8e-44]} {RNA1509_35784} {RNA1310_28475} |
23. | MligTC455_45880 | 278 | 5.8 | Mlig455_051498 | Neo: - Age: - Region-enriched R2: 5.081/0.00218 |
CALM2 | 2.515 | - | - | 0.752 | 0.965 | 0.798 | - | Mlig455_051498 {REF} {Length: 2328} {Pfam: EF-hand domain pair [PF13499.8, score=48.0]; EF-hand domain [PF14658.8, score=32.2]; EF-hand domain [PF13405.8, score=23.0]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=84.0, Expect=1e-20]; ENSG00000160014, CALM3, calmodulin 3, [Score=84.0, Expect=1e-20]; ENSG00000198668, CALM1, calmodulin 1, [Score=84.0, Expect=1e-20]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=84.0, Expect=9e-21]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=84.0, Expect=9e-21]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=84.0, Expect=9e-21]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=82.8, Expect=2e-20]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=82.8, Expect=1e-20]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=82.8, Expect=9e-21]} {RNA1509_41430} {RNA1310_44424} {RNA815_28870} |
24. | MligTC455_45881 | 285 | 5.94 | Mlig455_051535 | Neo: Irradiation Age: Up-Down-Down Region-enriched R2: 4.287/0.00883 |
CALM2 | 2.478 | - | - | 0.759 | 0.965 | 0.754 | - | Mlig455_051535 {REF} {Length: 1911} {Pfam: EF-hand domain pair [PF13499.8, score=44.7]; EF-hand domain [PF14658.8, score=28.5]; EF-hand domain [PF13405.8, score=18.6]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=83.2, Expect=5e-18]; ENSG00000198668, CALM1, calmodulin 1, [Score=83.2, Expect=1e-18]; ENSG00000160014, CALM3, calmodulin 3, [Score=82.8, Expect=2e-18]} {Mouse: ENSMUSG00000036438, Calm2, calmodulin 2, [Score=82.8, Expect=1e-18]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=82.8, Expect=1e-18]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=82.8, Expect=1e-18]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=82.4, Expect=2e-18]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=82.4, Expect=1e-18]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=82.4, Expect=1e-18]} {RNA1509_41430} {RNA1310_57772} {RNA815_28870} |
25. | MligTC455_19694 | 101 | 2.1 | Mlig455_019126 | Neo: - Age: - |
HMCN1 | 2.433 | - | - | - | 0.700 | 0.961 | 0.772 | Mlig455_019126 {REF} {Length: 1904} {Pfam: Immunoglobulin domain [PF13927.8, score=96.3]; Immunoglobulin I-set domain [PF07679.18, score=82.1]; Immunoglobulin V-set domain [PF07686.19, score=63.8]; Immunoglobulin domain [PF00047.27, score=57.8]; Immunoglobulin domain [PF13895.8, score=55.6]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=88.6, Expect=8e-18]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=92.0, Expect=5e-19]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=88.6, Expect=6e-18]} {Dmel: FBgn0000071, Ama, Amalgam, [RH, Score=111, Expect=7e-27]} {Celegans: WBGene00004372, rig-5, NeuRonal IGCAM, [RH, Score=98.2, Expect=6e-22]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=64.3, Expect=1e-10]} {RNA1310_49122} {RNA815_40619} |
26. | MligTC455_53609 | 596 | 12.41 | Mlig455_044296 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.314 Region-enriched R2: 5.752/0.03997 |
2.413 | - | - | 0.724 | 0.737 | 0.952 | - | Mlig455_044296 {REF} {Length: 1128} {RNA1509_40777} {RNA1310_31452.1} {RNA815_12344.1} | |
27. | MligTC455_14874 | 161 | 3.35 | Mlig455_029824 | Neo: - Age: - Region-enriched R2: 7.222/0.00004 |
CALM3 | 2.396 | 0.705 | - | - | 0.968 | 0.723 | - | Mlig455_029824 {REF} {Length: 1110} {Pfam: EF hand [PF00036.34, score=94.5]; EF-hand domain pair [PF13499.8, score=87.3]; EF-hand domain pair [PF13833.8, score=80.3]; EF-hand domain [PF13405.8, score=73.9]; EF hand [PF13202.8, score=62.9]; EF-hand domain [PF14658.8, score=36.9]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=27.6]; EF-hand domain [PF08976.13, score=22.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=19.8]; Ca2+ insensitive EF hand [PF08726.12, score=18.7]} {Human: ENSG00000160014, CALM3, calmodulin 3, [Score=130, Expect=1e-38]; ENSG00000198668, CALM1, calmodulin 1, [Score=130, Expect=1e-38]; ENSG00000143933, CALM2, calmodulin 2, [Score=130, Expect=1e-38]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=130, Expect=9e-39]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=130, Expect=9e-39]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=130, Expect=9e-39]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=127, Expect=1e-37]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=128, Expect=3e-38]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=128, Expect=2e-38]} {Smed: dd_Smed_v6_414_0_1, dd_Smed_v6_414_0_1, [Score=128, Expect=2e-38]} {RNA1310_51975.1} {RNA815_24980} |
28. | MligTC455_15077 | 77 | 1.61 | Mlig455_042805 | Neo: Irradiation |
B3GNT6 | 2.392 | - | - | 0.702 | 0.733 | 0.957 | - | Mlig455_042805 {REF} {Length: 1985} {Pfam: Galactosyltransferase [PF01762.23, score=133.9]} {Human: ENSG00000198488, B3GNT6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6, [Score=113, Expect=4e-27]; ENSG00000183778, B3GALT5, beta-1,3-galactosyltransferase 5, [Score=108, Expect=9e-26]} {Mouse: ENSMUSG00000074004, B3gnt6, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase), [Score=111, Expect=1e-26]} {Dmel: FBgn0035558, CG11357, [Score=145, Expect=1e-38]} {Celegans: WBGene00007104, B0024.15, Hexosyltransferase, [Score=74.7, Expect=1e-14]} {Smed: dd_Smed_v6_4748_0_1, dd_Smed_v6_4748_0_1, [Score=239, Expect=2e-75]} {RNA1509_8878} {RNA1310_14228.1} {RNA815_4876} |
29. | MligTC455_25415 | 1511 | 31.47 | Mlig455_035471 | Neo: - Age: logFC(26M/2M)=0.485 Region-enriched R2: 5.429/0.00000 |
2.391 | 0.715 | - | 0.706 | - | 0.970 | - | Mlig455_035471 {REF} {Length: 2953} {Dmel: FBgn0038642, Muc91C, Mucin 91C, [Score=51.2, Expect=2e-06]} {RNA1509_13942} {RNA1310_6517.1} {RNA815_12123} | |
30. | MligTC455_15890 | 18 | 0.38 | Mlig455_059636 | Neo: - Age: - |
CD209 | 1.988 | - | - | - | 0.998 | 0.990 | - | Mlig455_059636 {REF} {Length: 1223} {Pfam: Lectin C-type domain [PF00059.23, score=29.7]} {Human: ENSG00000090659, CD209, CD209 molecule, [Score=49.3, Expect=2e-06]} {Dmel: FBgn0040096, lectin-33A, [Score=48.9, Expect=6e-07]} {Smed: dd_Smed_v6_42798_0_1, dd_Smed_v6_42798_0_1, [Score=64.7, Expect=2e-12]} {RNA1509_20946} {RNA1310_53178} {RNA815_42043} |
31. | MligTC455_33442 | 39 | 0.81 | Mlig455_039767 | Neo: - Age: - |
1.981 | - | - | - | 0.997 | 0.984 | - | Mlig455_039767 {REF} {Length: 1975} {RNA1310_42391} | |
32. | MligTC455_53233 | 1483 | 30.9 | Mlig455_037746, Mlig455_069921 | Neo: - Age: - Region-specific R2: 7.323 Region-enriched R2: 7.524/0.00000 Regeneration-downregulated R2: -3.635 Regeneration-depleted R2: -3.635 |
PKD2 | 1.981 | - | - | - | 0.999 | 0.982 | - | Mlig455_037746 {REF} {Length: 3024} {Pfam: Polycystin cation channel [PF08016.14, score=468.5]; Ion transport protein [PF00520.33, score=85.9]; EF-hand domain pair [PF13499.8, score=21.3]; EF hand [PF00036.34, score=21.2]; EF-hand domain [PF13405.8, score=18.2]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=708, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=306, Expect=2e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=379, Expect=1e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=719, Expect=0.0]} {RNA1509_30624, RNA1509_6992} {RNA1310_6033, RNA1509_30624} {RNA1509_30624, RNA815_1577.1} Mlig455_069921 {REF} {Length: 3030} {Pfam: Polycystin cation channel [PF08016.14, score=467.0]; Ion transport protein [PF00520.33, score=85.5]; EF hand [PF00036.34, score=21.3]; EF-hand domain pair [PF13499.8, score=21.3]; EF-hand domain [PF13405.8, score=18.3]} {Human: ENSG00000118762, PKD2, polycystin 2, transient receptor potential cation channel, [RH, Score=707, Expect=0.0]} {Mouse: ENSMUSG00000034462, Pkd2, polycystic kidney disease 2, [RH, Score=699, Expect=0.0]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [RH, Score=304, Expect=8e-90]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [RH, Score=377, Expect=3e-119]} {Smed: dd_Smed_v6_17348_0_3, dd_Smed_v6_17348_0_3, [RH, Score=716, Expect=0.0]} {RNA1509_6992} {RNA1310_6033, RNA1509_6992} {RNA1509_6992, RNA815_1577.1} |
33. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
1.978 | - | - | - | 0.988 | 0.990 | - | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
34. | MligTC455_18384 | 52 | 1.08 | Mlig455_033464, Mlig455_033480 | Neo: - Age: - |
CHRNB3 | 1.978 | - | - | - | 0.988 | 0.990 | - | Mlig455_033464 {REF} {Length: 3273} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=101.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=28.0]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=112, Expect=2e-26]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=107, Expect=4e-25]; ENSMUSG00000035594, Chrna5, cholinergic receptor, nicotinic, alpha polypeptide 5, [Score=102, Expect=2e-23]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=95.5, Expect=5e-21]} {Celegans: WBGene00000058, acr-19, AcetylCholine Receptor; Acetylcholine receptor (63.2 kD) (Acr-19), [Score=98.2, Expect=5e-22]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=90.5, Expect=1e-19]} {RNA1509_28510} {RNA1310_44183.1} {RNA815_32188} Mlig455_033480 {REF} {Length: 904} {RNA1310_131495} |
35. | MligTC455_27785 | 115 | 2.39 | Mlig455_001141 | Neo: - |
HMCN2 | 1.972 | - | - | - | 0.984 | 0.988 | - | Mlig455_001141 {REF} {Length: 2156} {Pfam: von Willebrand factor type A domain [PF13519.8, score=54.7]; von Willebrand factor type A domain [PF13768.8, score=30.6]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=81.3, Expect=2e-15]} {Mouse: ENSMUSG00000007030, Vwa7, von Willebrand factor A domain containing 7, [Score=79.0, Expect=6e-15]; ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=2e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=96.3, Expect=1e-20]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=79.7, Expect=2e-15]} {RNA1509_38050} {RNA1310_19586} {RNA815_17693} |
36. | MligTC455_34518 | 327 | 6.81 | Mlig455_049366, Mlig455_062300 | Neo: - Age: - Region-enriched R2: 6.673/0.00158 |
DMRTA2 | 1.969 | - | - | - | 0.984 | 0.985 | - | Mlig455_049366 {REF} {Length: 1964} {Pfam: DM DNA binding domain [PF00751.20, score=82.7]; DMRTA motif [PF03474.16, score=39.9]} {Human: ENSG00000142700, DMRTA2, DMRT like family A2, [RH, Score=155, Expect=4e-41]} {Mouse: ENSMUSG00000047143, Dmrta2, doublesex and mab-3 related transcription factor like family A2, [RH, Score=154, Expect=1e-40]} {Dmel: FBgn0039683, dmrt99B, doublesex-Mab related 99B, [RH, Score=159, Expect=1e-42]} {Celegans: WBGene00017326, dmd-5, DM (Doublesex/MAB-3) Domain family, [RH, Score=139, Expect=7e-38]} {Smed: dd_Smed_v6_31674_0_1, dd_Smed_v6_31674_0_1, [RH, Score=137, Expect=9e-38]} {RNA1310_36206} {RNA815_36280} Mlig455_062300 {REF} {Length: 2056} {Pfam: DM DNA binding domain [PF00751.20, score=82.7]; DMRTA motif [PF03474.16, score=39.9]} {Human: ENSG00000142700, DMRTA2, DMRT like family A2, [RH, Score=155, Expect=4e-41]} {Mouse: ENSMUSG00000047143, Dmrta2, doublesex and mab-3 related transcription factor like family A2, [RH, Score=154, Expect=1e-40]} {Dmel: FBgn0039683, dmrt99B, doublesex-Mab related 99B, [RH, Score=159, Expect=1e-42]} {Celegans: WBGene00017326, dmd-5, DM (Doublesex/MAB-3) Domain family, [RH, Score=139, Expect=8e-38]} {Smed: dd_Smed_v6_31674_0_1, dd_Smed_v6_31674_0_1, [RH, Score=137, Expect=8e-38]} {RNA1310_36206} {RNA815_36280} |
37. | MligTC455_45569 | 10 | 0.2 | Mlig455_050997 | Neo: - Age: - |
NPFFR2 | 1.967 | - | - | - | 0.988 | 0.979 | - | Mlig455_050997 {REF} {Length: 1679} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=95.0]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=74.7, Expect=9e-14]; ENSG00000102239, BRS3, bombesin receptor subtype 3, [Score=74.3, Expect=1e-13]} {Mouse: ENSMUSG00000031130, Brs3, bombesin-like receptor 3, [Score=72.0, Expect=4e-13]; ENSMUSG00000019865, Nmbr, neuromedin B receptor, [Score=69.3, Expect=2e-12]; ENSMUSG00000035528, Npffr2, neuropeptide FF receptor 2, [Score=68.6, Expect=5e-12]; ENSMUSG00000031364, Grpr, gastrin releasing peptide receptor, [Score=68.6, Expect=4e-12]} {Dmel: FBgn0035610, Lkr, Leucokinin receptor, [Score=84.7, Expect=3e-17]} {Celegans: WBGene00006576, tkr-1, Probable G-protein coupled receptor tkr-1, [Score=65.9, Expect=2e-11]} {Smed: dd_Smed_v6_15625_0_1, dd_Smed_v6_15625_0_1, [Score=76.6, Expect=6e-15]} |
38. | MligTC455_41011 | 90 | 1.87 | Mlig455_014030, Mlig455_014036 | Neo: - Age: Down-Up-Down |
1.965 | - | - | - | 0.976 | 0.989 | - | Mlig455_014030 {REF} {Length: 1659} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=41.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=36.2]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=95.1, Expect=2e-21]} {RNA1310_70554} {RNA815_47734} Mlig455_014036 {REF} {Length: 1980} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=51.3]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=47.7]} {Smed: dd_Smed_v6_19397_0_1, dd_Smed_v6_19397_0_1, [Score=104, Expect=3e-24]} {RNA1310_70554} {RNA815_47734} |
|
39. | MligTC455_45622 | 647 | 13.48 | Mlig455_069391 | Neo: - Age: - Region-specific R2: 5.132 Region-enriched R2: 3.915/0.00000 Regeneration-downregulated R2: -2.412 Regeneration-depleted R2: -2.412 |
1.963 | - | - | - | 0.985 | 0.978 | - | Mlig455_069391 {REF} {Length: 971} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982} {RNA1310_46295} {RNA815_23543} | |
40. | MligTC455_53633 | 1960 | 40.84 | Mlig455_043831, Mlig455_047417, Mlig455_070992 | Neo: - Age: - Region-specific R2: 8.211 Region-enriched R2: 9.874/0.00000 |
1.963 | - | - | - | 0.988 | 0.975 | - | Mlig455_043831 {REF} {Length: 1456} {RNA1509_16856} {RNA1310_25970.1, RNA1509_16856} {RNA1509_16856, RNA815_11970} Mlig455_047417 {REF} {Length: 1354} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} Mlig455_070992 {REF} {Length: 1455} {RNA1509_16856} {RNA1310_25970.1} {RNA815_11970} |
|
41. | MligTC455_41448 | 192 | 4.01 | Mlig455_066626 | Neo: - Age: - Region-specific R2: 6.449 Region-enriched R2: 4.988/0.02499 |
1.959 | - | - | - | 0.985 | 0.974 | - | Mlig455_066626 {REF} {Length: 987} {Pfam: F5/8 type C domain [PF00754.27, score=25.0]} {Smed: dd_Smed_v6_83746_0_1, dd_Smed_v6_83746_0_1, [Score=52.4, Expect=8e-09]} {RNA1509_36923} {RNA1310_37535} {RNA815_20943} | |
42. | MligTC455_20088 | 39 | 0.81 | Mlig455_017821 | Neo: - Age: Up-Down-Down |
GLIPR1 | 1.956 | - | - | - | 0.996 | 0.960 | - | Mlig455_017821 {REF} {Length: 2083} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=62.2]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=89.4, Expect=2e-19]} {Mouse: ENSMUSG00000025431, Crisp1, cysteine-rich secretory protein 1, [RH, Score=84.3, Expect=5e-18]} {Dmel: FBgn0038126, CG8483, [Score=54.3, Expect=1e-07]} {Celegans: WBGene00003055, lon-1, LONg, [Score=78.6, Expect=5e-16]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=143, Expect=7e-37]} {RNA1310_43937.1} {RNA815_38891} |
43. | MligTC455_21801 | 58 | 1.22 | Mlig455_015442, Mlig455_032138 | Neo: - Age: - |
NPY1R | 1.955 | - | - | - | 0.973 | 0.982 | - | Mlig455_015442 {REF} {Length: 2461} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=130.0]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=26.2]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.9]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=128, Expect=5e-32]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=2e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=140, Expect=4e-36]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=120, Expect=1e-29]} {Smed: dd_Smed_v6_25204_0_1, dd_Smed_v6_25204_0_1, [Score=208, Expect=2e-61]} {RNA1310_49156} {RNA815_43783} Mlig455_032138 {REF} {Length: 2633} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=129.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=25.9]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=18.6]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [Score=126, Expect=2e-31]} {Mouse: ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [Score=122, Expect=4e-30]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=136, Expect=1e-34]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=119, Expect=3e-29]} {Smed: dd_Smed_v6_25934_0_1, dd_Smed_v6_25934_0_1, [Score=207, Expect=5e-61]} {RNA1310_49156} {RNA815_43783} |
44. | MligTC455_03731 | 113 | 2.35 | Mlig455_066791 | Neo: - Age: - |
1.952 | - | - | - | 0.991 | 0.961 | - | Mlig455_066791 {REF} {Length: 1679} {Smed: dd_Smed_v6_13648_0_1, dd_Smed_v6_13648_0_1, [RH, Score=79.7, Expect=2e-16]} {RNA1509_58026} {RNA1310_23180, RNA1509_58026} {RNA1509_58026, RNA815_34008} | |
45. | MligTC455_43557 | 362 | 7.55 | Mlig455_059172, Mlig455_065527 | Neo: - Age: Down-Down-Up Region-specific R2: 6.284 Region-enriched R2: 5.832/0.00001 |
ANKRD63 | 1.947 | - | - | - | 0.989 | 0.958 | - | Mlig455_059172 {REF} {Length: 1739} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=53.2]; Ankyrin repeats (many copies) [PF13637.8, score=42.6]; Ankyrin repeat [PF13606.8, score=27.6]; Ankyrin repeats (many copies) [PF13857.8, score=27.1]; Ankyrin repeat [PF00023.32, score=25.9]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=67.4, Expect=7e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=49.3, Expect=7e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=49.3, Expect=4e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=81.3, Expect=1e-16]} {RNA1310_44826} {RNA815_62096} Mlig455_065527 {REF} {Length: 2998} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=52.3]; Ankyrin repeats (many copies) [PF13637.8, score=42.0]; Ankyrin repeats (many copies) [PF13857.8, score=26.7]; Ankyrin repeat [PF00023.32, score=26.0]; Ankyrin repeat [PF13606.8, score=22.6]} {Human: ENSG00000230778, ANKRD63, ankyrin repeat domain 63, [Score=68.2, Expect=7e-12]} {Mouse: ENSMUSG00000078137, Ankrd63, ankyrin repeat domain 63, [Score=68.2, Expect=6e-12]} {Dmel: FBgn0043884, mask, multiple ankyrin repeats single KH domain, [Score=50.1, Expect=5e-06]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=50.4, Expect=2e-06]} {Smed: dd_Smed_v6_10280_0_1, dd_Smed_v6_10280_0_1, [Score=80.9, Expect=2e-16]} {RNA1509_30872} {RNA1310_44826} {RNA815_62096} |
46. | MligTC455_45621 | 610 | 12.72 | Mlig455_041531 | Neo: - Age: - Region-specific R2: 5.645 Region-enriched R2: 4.169/0.00001 |
1.945 | - | - | - | 0.978 | 0.967 | - | Mlig455_041531 {REF} {Length: 1004} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=45.1, Expect=4e-07]} {RNA1509_31982, RNA1509_8166} {RNA1310_46295, RNA1509_31982, RNA1509_8166} {RNA1509_31982, RNA1509_8166, RNA815_23543} | |
47. | MligTC455_22212 | 1732 | 36.09 | Mlig455_009239, Mlig455_009645, Mlig455_037058 | Neo: - Age: logFC(26M/2M)=-0.722 Region-specific R2: 6.329 Region-enriched R2: 6.728/0.00000 |
LMNA | 1.943 | - | - | - | 0.966 | 0.977 | - | Mlig455_009239 {REF} {Length: 2842} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_009645 {REF} {Length: 2337} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286} {RNA1310_9741.1} {RNA815_3167} Mlig455_037058 {REF} {Length: 4944} {Pfam: Intermediate filament protein [PF00038.23, score=176.1]; Lamin Tail Domain [PF00932.21, score=51.0]; Myosin tail [PF01576.21, score=18.0]} {Human: ENSG00000160789, LMNA, lamin A/C, [Score=176, Expect=8e-47]} {Mouse: ENSMUSG00000028063, Lmna, lamin A, [Score=172, Expect=1e-45]} {Dmel: FBgn0002525, Lam, Lamin, [Score=189, Expect=9e-52]} {Celegans: WBGene00002050, ifa-1, Intermediate filament protein ifa-1, [RH, Score=404, Expect=6e-134]} {Smed: dd_Smed_v6_3871_0_1, dd_Smed_v6_3871_0_1, [RH, Score=563, Expect=0.0]} {RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1310_9741.1, RNA1509_18286, RNA1509_31019, RNA1509_37437} {RNA1509_18286, RNA1509_31019, RNA1509_37437, RNA815_3167} |
48. | MligTC455_32575 | 62 | 1.29 | Mlig455_024198 | Neo: - Age: logFC(26M/2M)=-0.353 |
FAT4 | 1.94 | - | - | - | 0.955 | 0.985 | - | Mlig455_024198 {REF} {Length: 7971} {Pfam: Cadherin domain [PF00028.19, score=704.5]; Cadherin-like [PF16184.7, score=77.6]; Cadherin-like [PF08266.14, score=39.5]} {Human: ENSG00000196159, FAT4, FAT atypical cadherin 4, [Score=501, Expect=3e-142]; ENSG00000107736, CDH23, cadherin related 23, [Score=498, Expect=1e-141]} {Mouse: ENSMUSG00000046743, Fat4, FAT atypical cadherin 4, [Score=514, Expect=1e-146]; ENSMUSG00000012819, Cdh23, cadherin 23 (otocadherin), [Score=504, Expect=1e-143]} {Dmel: FBgn0284247, ds, dachsous, [Score=457, Expect=3e-129]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=277, Expect=2e-74]} {Smed: dd_Smed_v6_7638_0_1, dd_Smed_v6_7638_0_1, [Score=276, Expect=8e-74]} {RNA1509_24504} {RNA1310_3168, RNA1509_24504} {RNA1509_24504, RNA815_13217} |
49. | MligTC455_32903 | 29 | 0.6 | Mlig455_037926 | Neo: - Age: - |
1.937 | - | - | - | 0.993 | 0.944 | - | Mlig455_037926 {REF} {Length: 1892} {RNA1310_57340} {RNA815_53132} | |
50. | MligTC455_32172 | 14 | 0.29 | Mlig455_015389 | Neo: Irradiation Age: - |
1.933 | - | - | - | 0.942 | 0.991 | - | Mlig455_015389 {REF} {Length: 1732} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=39.2]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=72.0, Expect=7e-14]} {RNA1509_23615} {RNA1310_5589.2} {RNA815_10426} | |
51. | MligTC455_15229 | 6 | 0.12 | Mlig455_032752 | Neo: - Age: - |
1.932 | - | - | - | 0.942 | 0.990 | - | Mlig455_032752 {REF} {Length: 1841} {Pfam: F5/8 type C domain [PF00754.27, score=51.0]; PAN-like domain [PF08277.14, score=26.2]} {Smed: dd_Smed_v6_1477_1_1, dd_Smed_v6_1477_1_1, [RH, Score=51.2, Expect=6e-08]} {RNA1509_36923} {RNA1310_46041} {RNA815_10591.1} | |
52. | MligTC455_11958 | 26 | 0.54 | Mlig455_035540 | Neo: - Age: - |
1.93 | - | - | - | 0.940 | 0.990 | - | Mlig455_035540 {REF} {Length: 976} {RNA1509_48973} {RNA1310_39954.1} {RNA815_19596} | |
53. | MligTC455_12037 | 183 | 3.81 | Mlig455_016647, Mlig455_016711 | Neo: - Age: Down-Up-Up |
DYNLL1 | 1.93 | - | - | - | 0.989 | 0.941 | - | Mlig455_016647 {REF} {Length: 879} {Pfam: Dynein light chain type 1 [PF01221.20, score=69.4]} {Human: ENSG00000088986, DYNLL1, dynein light chain LC8-type 1, [Score=62.8, Expect=7e-14]; ENSG00000264364, DYNLL2, dynein light chain LC8-type 2, [Score=60.1, Expect=7e-13]} {Mouse: ENSMUSG00000009013, Dynll1, dynein light chain LC8-type 1, [Score=62.8, Expect=4e-14]; ENSMUSG00000020483, Dynll2, dynein light chain LC8-type 2, [Score=60.1, Expect=5e-13]} {Dmel: FBgn0011760, ctp, cut up, [Score=60.5, Expect=2e-13]} {Celegans: WBGene00001005, dlc-1, Dynein light chain 1, cytoplasmic, [Score=59.3, Expect=6e-13]} {Smed: dd_Smed_v6_10084_0_2, dd_Smed_v6_10084_0_2, [Score=65.9, Expect=1e-15]} {RNA1509_36890} {RNA1310_30005} {RNA815_41098} Mlig455_016711 {REF} {Length: 890} {Pfam: Dynein light chain type 1 [PF01221.20, score=69.4]} {Human: ENSG00000088986, DYNLL1, dynein light chain LC8-type 1, [Score=62.8, Expect=5e-14]; ENSG00000264364, DYNLL2, dynein light chain LC8-type 2, [Score=60.1, Expect=7e-13]} {Mouse: ENSMUSG00000009013, Dynll1, dynein light chain LC8-type 1, [Score=62.8, Expect=4e-14]; ENSMUSG00000020483, Dynll2, dynein light chain LC8-type 2, [Score=60.1, Expect=5e-13]} {Dmel: FBgn0011760, ctp, cut up, [Score=60.8, Expect=2e-13]} {Celegans: WBGene00001005, dlc-1, Dynein light chain 1, cytoplasmic, [Score=59.3, Expect=5e-13]} {Smed: dd_Smed_v6_10084_0_5, dd_Smed_v6_10084_0_5, [Score=65.9, Expect=1e-15]} {RNA1509_36890} {RNA1310_30005} {RNA815_41098} |
54. | MligTC455_19917 | 83 | 1.72 | Mlig455_057932, Mlig455_057967 | Neo: - Age: - |
1.93 | - | - | - | - | 0.982 | 0.948 | Mlig455_057932 {REF} {Length: 2189} {RNA1310_65401} {RNA815_48417} Mlig455_057967 {REF} {Length: 1876} {RNA1310_65401} {RNA815_48417} |
|
55. | MligTC455_48720 | 1367 | 28.48 | Mlig455_017034 | Neo: - Age: - Region-specific R2: 4.593 Region-enriched R2: 3.164/0.00157 |
1.926 | - | - | - | 0.969 | 0.957 | - | Mlig455_017034 {REF} {Length: 866} {RNA1509_17554, RNA1509_28146} {RNA1310_40772, RNA1509_28146} {RNA1509_28146, RNA815_29897} | |
56. | MligTC455_12397 | 18 | 0.37 | Mlig455_021272 | Neo: - Age: - |
SCNN1G | 1.922 | - | - | - | 0.942 | 0.980 | - | Mlig455_021272 {REF} {Length: 2377} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=191.3]} {Human: ENSG00000166828, SCNN1G, sodium channel epithelial 1 gamma subunit, [Score=52.0, Expect=3e-06]} {Mouse: ENSMUSG00000000216, Scnn1g, sodium channel, nonvoltage-gated 1 gamma, [Score=49.7, Expect=1e-05]} {Celegans: WBGene00006832, unc-105, Degenerin-like protein unc-105, [Score=70.1, Expect=3e-12]} {Smed: dd_Smed_v6_12878_0_1, dd_Smed_v6_12878_0_1, [Score=103, Expect=7e-23]} {RNA1310_124026} |
57. | MligTC455_24244 | 290 | 6.04 | Mlig455_062623, Mlig455_067528, Mlig455_070336 | Neo: - Age: Down-Up-Down Region-enriched R2: 6.603/0.00020 |
1.921 | - | - | - | 0.953 | 0.968 | - | Mlig455_062623 {REF} {Length: 1154} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=68.1]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=71.6, Expect=3e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_067528 {REF} {Length: 1190} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.0]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [RH, Score=72.4, Expect=1e-16]} {RNA1310_40891} {RNA815_16565} Mlig455_070336 {REF} {Length: 859} {Pfam: Putative Interleukin 2 receptor, gamma chain [PF15874.7, score=67.7]} {Smed: dd_Smed_v6_15167_0_1, dd_Smed_v6_15167_0_1, [Score=57.4, Expect=1e-10]} {RNA1310_40891} {RNA815_16565} |
|
58. | MligTC455_12525 | 11 | 0.23 | Mlig455_067862 | Neo: - Age: - |
1.92 | - | - | - | 0.942 | 0.978 | - | Mlig455_067862 {REF} {Length: 1730} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=44.0]; TcdA/TcdB catalytic glycosyltransferase domain [PF12919.9, score=18.1]} {Smed: dd_Smed_v6_13661_0_2, dd_Smed_v6_13661_0_2, [Score=80.9, Expect=3e-17]} {RNA1509_20770} {RNA1310_58410} {RNA815_35907} | |
59. | MligTC455_13165 | 181 | 3.77 | Mlig455_018648 | Neo: - Age: - Region-specific R2: 6.131 Region-enriched R2: 4.463/0.01828 Regeneration-downregulated R2: -3.253 Regeneration-depleted R2: -3.253 |
1.92 | - | - | - | 0.996 | 0.924 | - | Mlig455_018648 {REF} {Length: 1920} {TRANSSPLICED} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_25789} {RNA1310_15994} {RNA815_21830} | |
60. | MligTC455_49557 | 280 | 5.82 | Mlig455_017273 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.728 Region-specific R2: 3.642 Region-enriched R2: 3.187/0.00196 |
1.92 | - | - | - | 0.943 | 0.977 | - | Mlig455_017273 {REF} {Length: 1333} {RNA1509_52848} {RNA1310_64923, RNA1509_52848} {RNA1509_52848, RNA815_51063} | |
61. | MligTC455_45620 | 1952 | 40.67 | Mlig455_002357 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.487/0.00094 Regeneration-depleted BL: -3.636 |
1.919 | - | - | - | 0.955 | 0.964 | - | Mlig455_002357 {REF} {Length: 933} {RNA1509_8166} {RNA1310_46295} {RNA815_23543} | |
62. | MligTC455_11957 | 20 | 0.41 | Mlig455_019238 | Neo: - Age: - |
1.918 | - | - | - | 0.928 | 0.990 | - | Mlig455_019238 {REF} {Length: 956} {RNA1509_48973} {RNA1310_39954.1} {RNA815_19596} | |
63. | MligTC455_25412 | 199 | 4.15 | Mlig455_008720, Mlig455_063581 | Neo: - Age: - Region-enriched R2: 7.484/0.00035 |
CNBD2 | 1.917 | - | - | - | 0.965 | 0.952 | - | Mlig455_008720 {REF} {Length: 2602} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.1]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=1e-69]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} Mlig455_063581 {REF} {Length: 2668} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=82.3]} {Human: ENSG00000149646, CNBD2, cyclic nucleotide binding domain containing 2, [Score=52.4, Expect=3e-06]} {Smed: dd_Smed_v6_13623_0_1, dd_Smed_v6_13623_0_1, [Score=241, Expect=7e-70]} {RNA1509_50931} {RNA1310_3304} {RNA815_12767} |
64. | MligTC455_37058 | 19 | 0.4 | Mlig455_061075 | Neo: - Age: - |
1.915 | - | - | - | 0.938 | 0.977 | - | Mlig455_061075 {REF} {Length: 4598} {Pfam: IQ calmodulin-binding motif [PF00612.29, score=31.8]} {RNA1509_56135} {RNA1310_6435} {RNA815_17633} | |
65. | MligTC455_14149 | 226 | 4.71 | Mlig455_017664, Mlig455_017690, Mlig455_017741 | Neo: - Age: Up-Down-Down |
SLC6A5 | 1.914 | - | - | - | 0.937 | 0.977 | - | Mlig455_017664 {REF} {Length: 2439} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=584.2]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=510, Expect=5e-171]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=509, Expect=7e-171]} {Dmel: FBgn0034911, CG5549, [Score=509, Expect=3e-166]} {Celegans: WBGene00004902, snf-3, Sodium- and chloride-dependent betaine transporter, [Score=373, Expect=1e-120]} {Smed: dd_Smed_v6_10458_0_2, dd_Smed_v6_10458_0_2, [Score=500, Expect=2e-169]} {RNA1509_52349} {RNA1310_8571.2} {RNA815_10787} Mlig455_017690 {REF} {Length: 2567} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=581.8]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=513, Expect=4e-172]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=512, Expect=8e-172]} {Dmel: FBgn0034911, CG5549, [Score=520, Expect=2e-170]} {Celegans: WBGene00004902, snf-3, Sodium- and chloride-dependent betaine transporter, [Score=371, Expect=5e-120]} {Smed: dd_Smed_v6_10458_0_1, dd_Smed_v6_10458_0_1, [Score=502, Expect=1e-169]} {RNA1509_52349} {RNA1310_8571.1, RNA1509_52349} {RNA1509_52349, RNA815_10787} Mlig455_017741 {REF} {Length: 2497} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=582.2]} {Human: ENSG00000165970, SLC6A5, solute carrier family 6 member 5, [Score=518, Expect=1e-173]} {Mouse: ENSMUSG00000039728, Slc6a5, solute carrier family 6 (neurotransmitter transporter, glycine), member 5, [Score=516, Expect=3e-173]} {Dmel: FBgn0034911, CG5549, [Score=519, Expect=8e-170]} {Celegans: WBGene00004902, snf-3, Sodium- and chloride-dependent betaine transporter, [Score=371, Expect=1e-119]} {Smed: dd_Smed_v6_10458_0_1, dd_Smed_v6_10458_0_1, [Score=511, Expect=8e-173]} {RNA1509_52349} {RNA1310_8571.1} {RNA815_10787} |
66. | MligTC455_23100 | 527 | 10.99 | Mlig455_019660 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.306 Region-enriched R2: 3.360/0.00019 |
1.914 | - | - | - | 0.962 | 0.952 | - | Mlig455_019660 {REF} {Length: 2113} {RNA1509_29678} {RNA1310_49452, RNA1509_29678} {RNA1509_29678, RNA815_4585} | |
67. | MligTC455_01243 | 37 | 0.77 | Mlig455_055650 | Neo: - Age: - |
1.913 | - | - | - | 0.935 | 0.978 | - | Mlig455_055650 {REF} {Length: 625} {Pfam: Universal stress protein family [PF00582.28, score=20.0]} {RNA1310_33871} {RNA815_28361} | |
68. | MligTC455_32171 | 15 | 0.3 | Mlig455_015340 | Neo: - Age: - |
1.913 | - | - | - | 0.923 | 0.990 | - | Mlig455_015340 {REF} {Length: 2137} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=38.6]} {Smed: dd_Smed_v6_31564_0_1, dd_Smed_v6_31564_0_1, [Score=72.8, Expect=4e-14]} {RNA1509_41917} {RNA1310_48467} {RNA815_13028} | |
69. | MligTC455_50435 | 8697 | 181.19 | Mlig455_039060 | Neo: - Age: logFC(26M/2M)=3.232 Region-enriched R2: 1.067/0.02505 Regeneration-downregulated BL: -1.692 Regeneration-depleted BL: -1.692 |
1.913 | - | - | - | 0.940 | 0.973 | - | Mlig455_039060 {REF} {Length: 1433} {Pfam: Thiazole biosynthesis protein ThiG [PF05690.16, score=31.0]; SOR/SNZ family [PF01680.19, score=29.1]; Histidine biosynthesis protein [PF00977.23, score=21.2]} {Smed: dd_Smed_v6_1240_0_1, dd_Smed_v6_1240_0_1, [Score=162, Expect=2e-50]} {RNA1509_1321} {RNA1310_25568} {RNA815_8446.1} | |
70. | MligTC455_50436 | 8699 | 181.24 | Mlig455_039065 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=-0.358 Region-enriched R2: 1.068/0.02488 Regeneration-downregulated BL: -1.693 Regeneration-depleted BL: -1.693 |
1.913 | - | - | - | 0.940 | 0.973 | - | Mlig455_039065 {REF} {Length: 1569} {Pfam: SOR/SNZ family [PF01680.19, score=359.9]; Thiazole biosynthesis protein ThiG [PF05690.16, score=37.0]; Histidine biosynthesis protein [PF00977.23, score=21.5]; Dihydrouridine synthase (Dus) [PF01207.19, score=19.8]; Indole-3-glycerol phosphate synthase [PF00218.23, score=19.4]} {Smed: dd_Smed_v6_1240_0_1, dd_Smed_v6_1240_0_1, [RH, Score=441, Expect=1e-157]} {RNA1509_1321, RNA1509_4701} {RNA1310_25568, RNA1509_4701} {RNA1509_4701, RNA815_8446.1} | |
71. | MligTC455_24951 | 220 | 4.58 | Mlig455_052169 | Neo: - Age: - Region-specific R2: 4.554 Region-enriched R2: 4.264/0.00008 Regeneration-downregulated R2: -1.743 Regeneration-depleted R2: -1.743 |
CCDC169 | 1.911 | - | - | - | 0.971 | 0.940 | - | Mlig455_052169 {REF} {Length: 1369} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} |
72. | MligTC455_09509 | 46 | 0.95 | Mlig455_042043 | Neo: - Age: - |
1.909 | - | - | - | - | 0.964 | 0.945 | Mlig455_042043 {REF} {Length: 1543} {Pfam: SICA C-terminal inner membrane domain [PF12879.9, score=63.2]} {RNA1509_50446} {RNA1310_8738.1} {RNA815_21682.1} | |
73. | MligTC455_48591 | 25 | 0.53 | Mlig455_047514, Mlig455_059649 | Neo: - Age: - |
NEUROD1 | 1.908 | - | - | - | - | 0.987 | 0.921 | Mlig455_047514 {REF} {Length: 1271} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=54.8]; Neuronal helix-loop-helix transcription factor [PF12533.10, score=51.0]} {Human: ENSG00000162992, NEUROD1, neuronal differentiation 1, [Score=140, Expect=1e-38]; ENSG00000164600, NEUROD6, neuronal differentiation 6, [Score=136, Expect=1e-37]} {Mouse: ENSMUSG00000034701, Neurod1, neurogenic differentiation 1, [Score=139, Expect=1e-38]; ENSMUSG00000037984, Neurod6, neurogenic differentiation 6, [Score=133, Expect=1e-36]} {Dmel: FBgn0010433, ato, atonal, [Score=82.0, Expect=8e-18]} {Celegans: WBGene00000561, cnd-1, Neurogenic differentiation factor 1, [Score=127, Expect=6e-36]} {Smed: dd_Smed_v6_21717_0_1, dd_Smed_v6_21717_0_1, [RH, Score=136, Expect=2e-39]} {RNA1310_133631} {RNA815_38093} Mlig455_059649 {REF} {Length: 945} {Pfam: Neuronal helix-loop-helix transcription factor [PF12533.10, score=20.2]} {RNA1310_133631} {RNA815_38093} |
74. | MligTC455_13166 | 186 | 3.88 | Mlig455_018849 | Neo: - Age: - Region-specific R2: 6.227 |
1.907 | - | - | - | 0.996 | 0.911 | - | Mlig455_018849 {REF} {Length: 693} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=209.8]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=21.6]; FAD binding domain [PF01494.21, score=20.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=19.9]; FAD binding domain [PF00890.26, score=18.9]} {Mouse: ENSMUSG00000033624, Pdpr, pyruvate dehydrogenase phosphatase regulatory subunit, [Score=51.6, Expect=2e-06]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [RH, Score=246, Expect=2e-77]} {RNA1509_49819} {RNA1310_28647} {RNA815_1682.1} | |
75. | MligTC455_27332 | 6690 | 139.38 | Mlig455_034839, Mlig455_034841, Mlig455_034842 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=0.609 Region-specific R2: 8.988 Region-enriched R2: 9.169/0.00000 Regeneration-depleted R2: -8.701 |
1.906 | - | - | - | 0.918 | 0.988 | - | Mlig455_034839 {REF} {Length: 551} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} Mlig455_034841 {REF} {Length: 529} {RNA1509_2874} {RNA1310_102625.1, RNA1509_2874} {RNA1509_2874, RNA815_20834} Mlig455_034842 {REF} {Length: 557} {RNA1509_2874} {RNA1310_102625.1} {RNA815_20834} |
|
76. | MligTC455_32554 | 51 | 1.07 | Mlig455_024179 | Neo: - Age: - |
1.905 | - | - | - | 0.917 | 0.988 | - | Mlig455_024179 {REF} {Length: 926} {RNA1509_24504} {RNA1310_3168} {RNA815_18309} | |
77. | MligTC455_50437 | 8730 | 181.87 | Mlig455_042760 | Neo: - Age: logFC(26M/2M)=-0.331 Region-enriched R2: 1.062/0.03070 Regeneration-downregulated BL: -1.679 Regeneration-depleted BL: -1.679 |
1.905 | - | - | - | 0.946 | 0.959 | - | Mlig455_042760 {REF} {Length: 2445} {Pfam: SOR/SNZ family [PF01680.19, score=359.9]; Thiazole biosynthesis protein ThiG [PF05690.16, score=37.0]; Histidine biosynthesis protein [PF00977.23, score=21.5]; Dihydrouridine synthase (Dus) [PF01207.19, score=19.8]; Indole-3-glycerol phosphate synthase [PF00218.23, score=19.4]} {Smed: dd_Smed_v6_1240_0_1, dd_Smed_v6_1240_0_1, [RH, Score=441, Expect=1e-157]} {RNA1509_1321, RNA1509_1426, RNA1509_973} {RNA1310_25568, RNA1509_1321, RNA1509_1426, RNA1509_973} {RNA1509_1321, RNA1509_1426, RNA1509_973, RNA815_8446.1} | |
78. | MligTC455_37050 | 21 | 0.43 | Mlig455_058277, Mlig455_070789 | Neo: - Age: - |
1.903 | - | - | - | 0.912 | 0.991 | - | Mlig455_058277 {REF} {Length: 1417} {RNA1509_52793} {RNA1310_10196} {RNA815_19033} Mlig455_070789 {REF} {Length: 1065} {RNA1509_52793} {RNA1310_10196} {RNA815_19033} |
|
79. | MligTC455_17609 | 87 | 1.82 | Mlig455_059630, Mlig455_059644 | Neo: - Age: Up-Down-Down |
GALR2 | 1.902 | - | - | - | 0.934 | 0.968 | - | Mlig455_059630 {REF} {Length: 3780} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=154.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=38.7]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=27.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.7]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=5e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=134, Expect=6e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=111, Expect=2e-26]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=102, Expect=2e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=241, Expect=4e-75]} {RNA1310_55640} {RNA815_36728} Mlig455_059644 {REF} {Length: 3887} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=154.3]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=38.7]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=27.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.7]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=5e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=134, Expect=6e-35]} {Dmel: FBgn0036790, AstC-R1, Allatostatin C receptor 1, [Score=111, Expect=2e-26]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=102, Expect=2e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=241, Expect=4e-75]} {RNA1310_55640} {RNA815_36728} |
80. | MligTC455_26091 | 161 | 3.36 | Mlig455_047190 | Neo: - Age: - Region-enriched R2: 4.521/0.00020 |
1.902 | - | - | - | 0.924 | 0.978 | - | Mlig455_047190 {REF} {Length: 2450} {Pfam: Lectin C-type domain [PF00059.23, score=23.6]} {RNA1509_2912} {RNA1310_27113} {RNA815_24719} | |
81. | MligTC455_39423 | 421 | 8.77 | Mlig455_048451 | Neo: - Age: - Region-specific R2: 5.732 Region-enriched R2: 3.988/0.00696 |
TCTEX1D2 | 1.901 | - | - | - | 0.971 | 0.930 | - | Mlig455_048451 {REF} {Length: 954} {Pfam: Tctex-1 family [PF03645.15, score=51.0]} {Human: ENSG00000213123, TCTEX1D2, Tctex1 domain containing 2, [Score=60.8, Expect=2e-11]; ENSG00000184786, TCTE3, t-complex-associated-testis-expressed 3, [Score=58.2, Expect=4e-10]; ENSG00000275368, TCTE3, t-complex-associated-testis-expressed 3, [Score=58.2, Expect=4e-10]} {Mouse: ENSMUSG00000116780, Gm3417, predicted gene 3417, [RH, Score=62.8, Expect=6e-12]; ENSMUSG00000079710, Gm3448, predicted gene 3448, [RH, Score=62.0, Expect=1e-11]; ENSMUSG00000079707, Tcte3, t-complex-associated testis expressed 3, [RH, Score=62.0, Expect=1e-11]} {Dmel: FBgn0033243, CG14763, [RH, Score=61.6, Expect=8e-12]} {Smed: dd_Smed_v6_5494_0_1, dd_Smed_v6_5494_0_1, [RH, Score=69.7, Expect=5e-15]} {RNA1509_7908} {RNA1310_23636} {RNA815_10299} |
82. | MligTC455_42841 | 550 | 11.45 | Mlig455_019999 | Neo: - Age: logFC(26M/2M)=-0.374 Region-specific R2: 6.903 Region-enriched R2: 6.896/0.00000 |
DDC | 1.901 | - | - | - | 0.981 | 0.920 | - | Mlig455_019999 {REF} {Length: 3000} {Pfam: Pyridoxal-dependent decarboxylase conserved domain [PF00282.21, score=395.1]} {Human: ENSG00000132437, DDC, dopa decarboxylase, [Score=444, Expect=3e-151]} {Mouse: ENSMUSG00000020182, Ddc, dopa decarboxylase, [Score=436, Expect=5e-148]} {Dmel: FBgn0050446, Tdc2, Tyrosine decarboxylase 2, [Score=457, Expect=2e-154]} {Celegans: WBGene00006562, tdc-1, Tyrosine decarboxylase, [Score=445, Expect=1e-149]} {Smed: dd_Smed_v6_11320_0_1, dd_Smed_v6_11320_0_1, [Score=449, Expect=3e-153]} {RNA1509_57403} {RNA1310_9852} {RNA815_3388.1} |
83. | MligTC455_24952 | 637 | 13.28 | Mlig455_054178, Mlig455_060727 | Neo: - Age: Down-Up-Down Region-specific R2: 4.165 Region-enriched R2: 3.160/0.00003 Regeneration-downregulated BL: -4.774 Regeneration-depleted BL: -4.774 |
CCDC169 | 1.901 | - | - | - | 0.949 | 0.952 | - | Mlig455_054178 {REF} {Length: 1390} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029} {RNA815_11545} Mlig455_060727 {REF} {Length: 1391} {Pfam: Domain of unknown function (DUF4600) [PF15372.8, score=97.2]} {Human: ENSG00000242715, CCDC169, coiled-coil domain containing 169, [RH, Score=82.8, Expect=6e-19]} {Mouse: ENSMUSG00000048655, Ccdc169, coiled-coil domain containing 169, [RH, Score=94.0, Expect=3e-23]} {Smed: dd_Smed_v6_12011_0_1, dd_Smed_v6_12011_0_1, [RH, Score=207, Expect=9e-68]} {RNA1509_8270} {RNA1310_23029, RNA1509_8270} {RNA1509_8270, RNA815_11545} |
84. | MligTC455_38065 | 47 | 0.98 | Mlig455_054213 | Neo: - Age: - |
KREMEN2 | 1.89 | - | - | - | 0.899 | 0.991 | - | Mlig455_054213 {REF} {Length: 924} {Pfam: WSC domain [PF01822.21, score=68.9]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=1e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=52.0, Expect=1e-07]} {RNA1509_53783} {RNA1310_43773} {RNA815_23638} |
85. | MligTC455_39424 | 443 | 9.24 | Mlig455_062724 | Neo: - Age: logFC(26M/2M)=-0.363 Region-specific R2: 5.676 Region-enriched R2: 4.122/0.00336 |
TCTEX1D2 | 1.89 | - | - | - | 0.972 | 0.918 | - | Mlig455_062724 {REF} {Length: 1719} {Pfam: Tctex-1 family [PF03645.15, score=54.9]} {Human: ENSG00000213123, TCTEX1D2, Tctex1 domain containing 2, [Score=62.0, Expect=6e-12]; ENSG00000275368, TCTE3, t-complex-associated-testis-expressed 3, [Score=60.1, Expect=7e-11]; ENSG00000184786, TCTE3, t-complex-associated-testis-expressed 3, [Score=60.1, Expect=7e-11]} {Mouse: ENSMUSG00000116780, Gm3417, predicted gene 3417, [RH, Score=63.9, Expect=2e-12]; ENSMUSG00000079710, Gm3448, predicted gene 3448, [RH, Score=63.2, Expect=3e-12]; ENSMUSG00000079707, Tcte3, t-complex-associated testis expressed 3, [RH, Score=63.2, Expect=3e-12]} {Dmel: FBgn0033243, CG14763, [RH, Score=63.2, Expect=2e-12]} {Smed: dd_Smed_v6_12108_0_1, dd_Smed_v6_12108_0_1, [Score=67.0, Expect=5e-14]} {RNA1509_7908} {RNA1310_23636, RNA1509_7908} {RNA1509_7908, RNA815_10299} |
86. | MligTC455_21665 | 1283 | 26.74 | Mlig455_000443, Mlig455_000504 | Neo: - Age: logFC(26M/2M)=-0.231 Region-specific R2: 3.326 Region-enriched R2: 2.174/0.00141 |
PPP3R1 | 1.889 | - | - | - | 0.933 | 0.956 | - | Mlig455_000443 {REF} {Length: 1489} {Pfam: EF hand [PF00036.34, score=92.6]; EF-hand domain pair [PF13499.8, score=86.6]; EF-hand domain [PF13405.8, score=74.3]; EF hand [PF13202.8, score=72.6]; EF-hand domain pair [PF13833.8, score=65.7]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=30.2]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=27.0]; EF-hand domain [PF14658.8, score=21.7]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=289, Expect=5e-101]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=289, Expect=3e-101]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=282, Expect=1e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=272, Expect=7e-95]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=281, Expect=1e-98]} {RNA1509_14613, RNA1509_39549} {RNA1310_16848.2, RNA1509_14613, RNA1509_39549} {RNA1509_14613, RNA1509_39549, RNA815_6272} Mlig455_000504 {REF} {Length: 1689} {Pfam: EF hand [PF00036.34, score=90.0]; EF-hand domain pair [PF13499.8, score=84.5]; EF-hand domain [PF13405.8, score=71.9]; EF hand [PF13202.8, score=69.8]; EF-hand domain pair [PF13833.8, score=63.4]; Cytoskeletal-regulatory complex EF hand [PF12763.9, score=28.7]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=25.4]; EF-hand domain [PF14658.8, score=19.6]} {Human: ENSG00000221823, PPP3R1, protein phosphatase 3 regulatory subunit B, alpha, [RH, Score=290, Expect=2e-100]} {Mouse: ENSMUSG00000033953, Ppp3r1, protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I), [RH, Score=290, Expect=1e-100]} {Dmel: FBgn0010014, CanB, Calcineurin B, [RH, Score=283, Expect=4e-98]} {Celegans: WBGene00000554, cnb-1, Protein phosphatase 2B regulatory subunit cnb-1, [RH, Score=274, Expect=3e-94]} {Smed: dd_Smed_v6_5589_0_1, dd_Smed_v6_5589_0_1, [RH, Score=283, Expect=3e-98]} {RNA1509_39549} {RNA1310_16848.2} {RNA815_6272} |
87. | MligTC455_20716 | 118 | 2.46 | Mlig455_010285 | Neo: - Age: - |
ZSCAN20 | 1.887 | - | - | - | - | 0.963 | 0.924 | Mlig455_010285 {REF} {Length: 4457} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=70.7]; C2H2-type zinc finger [PF13894.8, score=67.4]; Zinc-finger double domain [PF13465.8, score=65.0]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=44.0]; Zinc-finger of C2H2 type [PF12874.9, score=24.0]} {Human: ENSG00000121903, ZSCAN20, zinc finger and SCAN domain containing 20, [Score=86.3, Expect=2e-16]; ENSG00000147118, ZNF182, zinc finger protein 182, [Score=85.5, Expect=2e-16]; ENSG00000166526, ZNF3, zinc finger protein 3, [Score=85.5, Expect=1e-16]; ENSG00000186300, ZNF555, zinc finger protein 555, [Score=85.5, Expect=2e-16]; ENSG00000114853, ZBTB47, zinc finger and BTB domain containing 47, [Score=84.3, Expect=5e-16]; ENSG00000196724, ZNF418, zinc finger protein 418, [Score=84.0, Expect=6e-16]; ENSG00000197566, ZNF624, zinc finger protein 624, [Score=84.0, Expect=8e-16]; ENSG00000085274, MYNN, myoneurin, [Score=83.6, Expect=8e-16]; ENSG00000172748, ZNF596, zinc finger protein 596, [Score=83.6, Expect=5e-16]; ENSG00000131845, ZNF304, zinc finger protein 304, [Score=82.8, Expect=1e-15]; ENSG00000112365, ZBTB24, zinc finger and BTB domain containing 24, [Score=82.8, Expect=2e-15]; ENSG00000116809, ZBTB17, zinc finger and BTB domain containing 17, [Score=82.4, Expect=2e-15]; ENSG00000018869, ZNF582, zinc finger protein 582, [Score=82.4, Expect=1e-15]; ENSG00000227124, ZNF717, zinc finger protein 717, [Score=82.4, Expect=2e-15]; ENSG00000198740, ZNF652, zinc finger protein 652, [Score=82.4, Expect=2e-15]; ENSG00000198551, ZNF627, zinc finger protein 627, [Score=82.0, Expect=1e-15]; ENSG00000197213, ZSCAN5B, zinc finger and SCAN domain containing 5B, [Score=82.0, Expect=2e-15]} {Mouse: ENSMUSG00000056019, Zfp709, zinc finger protein 709, [Score=93.2, Expect=6e-19]; ENSMUSG00000091474, 2610021A01Rik, RIKEN cDNA 2610021A01 gene, [Score=90.5, Expect=6e-18]; ENSMUSG00000054737, Zfp182, zinc finger protein 182, [Score=90.5, Expect=5e-18]} {Dmel: FBgn0266450, Kr-h1, Kruppel homolog 1, [Score=87.4, Expect=3e-17]} {Celegans: WBGene00021931, Y55F3AM.14, [Score=90.5, Expect=2e-18]} {Smed: dd_Smed_v6_10911_0_1, dd_Smed_v6_10911_0_1, [RH, Score=121, Expect=6e-28]} {RNA1509_31474} {RNA1310_28516} {RNA815_22110} |
88. | MligTC455_09595 | 48 | 1.01 | Mlig455_030009 | Neo: - Age: - |
OPRM1 | 1.886 | - | - | - | 0.980 | 0.906 | - | Mlig455_030009 {REF} {Length: 1508} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=44.4]; Serpentine type 7TM GPCR chemoreceptor Sra [PF02117.18, score=19.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=19.6]} {Human: ENSG00000112038, OPRM1, opioid receptor mu 1, [Score=56.2, Expect=5e-08]} {Mouse: ENSMUSG00000000766, Oprm1, opioid receptor, mu 1, [Score=54.7, Expect=9e-08]} {Celegans: WBGene00021510, frpr-19, FMRFamide Peptide Receptor family, [Score=47.8, Expect=7e-06]} {RNA1310_43388} {RNA815_47203} |
89. | MligTC455_47736 | 1775 | 36.98 | Mlig455_054650 | Neo: - Age: logFC(26M/2M)=-0.375 Region-enriched R3: 5.288/0.00000 |
1.884 | 0.924 | - | - | 0.960 | - | - | Mlig455_054650 {REF} {Length: 1247} {Pfam: Domain of unknown function (DUF4573) [PF15140.8, score=86.5]} {RNA1509_13769, RNA1509_51431} {RNA1310_40941.1, RNA1509_13769, RNA1509_51431} {RNA1509_13769, RNA1509_51431, RNA815_34286.1} | |
90. | MligTC455_32612 | 55 | 1.15 | Mlig455_015630 | Neo: - Age: - Region-enriched R2: 5.626/0.02523 |
ARX | 1.88 | - | - | - | - | 0.977 | 0.903 | Mlig455_015630 {REF} {Length: 2012} {Pfam: Homeodomain [PF00046.31, score=83.5]} {Human: ENSG00000004848, ARX, aristaless related homeobox, [RH, Score=134, Expect=1e-34]} {Mouse: ENSMUSG00000035277, Arx, aristaless related homeobox, [RH, Score=133, Expect=1e-34]} {Dmel: FBgn0000061, al, aristaless, [RH, Score=130, Expect=3e-34]} {Celegans: WBGene00044330, alr-1, AristaLess (Drosophila homeodomain) Related, [RH, Score=118, Expect=2e-30]} {Smed: dd_Smed_v6_63359_0_1, dd_Smed_v6_63359_0_1, [Score=119, Expect=3e-33]} {RNA1310_42333.1} {RNA815_48205} |
91. | MligTC455_46775 | 3655 | 76.14 | Mlig455_034423 | Neo: - Age: - Region-enriched R2: 6.976/0.00000 |
CAV1 | 1.878 | - | - | - | 0.991 | 0.887 | - | Mlig455_034423 {REF} {Length: 1041} {Pfam: Caveolin [PF01146.19, score=114.3]} {Human: ENSG00000105974, CAV1, caveolin 1, [Score=94.7, Expect=4e-25]; ENSG00000182533, CAV3, caveolin 3, [Score=92.4, Expect=3e-24]} {Mouse: ENSMUSG00000007655, Cav1, caveolin 1, caveolae protein, [Score=92.4, Expect=2e-24]; ENSMUSG00000062694, Cav3, caveolin 3, [Score=91.3, Expect=6e-24]} {Celegans: WBGene00000301, cav-1, Caveolin-1, [Score=70.9, Expect=1e-15]} {Smed: dd_Smed_v6_8555_0_1, dd_Smed_v6_8555_0_1, [Score=130, Expect=1e-39]} {RNA1509_5585, RNA1509_8418} {RNA1310_21291.2, RNA1509_5585, RNA1509_8418} {RNA1509_5585, RNA1509_8418, RNA815_11992} |
92. | MligTC455_19526 | 40 | 0.84 | Mlig455_032263 | Neo: - Age: - Region-enriched R5: 4.476/0.00075 |
1.876 | - | - | - | 0.924 | 0.952 | - | Mlig455_032263 {REF} {Length: 986} {RNA1509_59284} {RNA1310_56370} {RNA815_27780} | |
93. | MligTC455_41993 | 177 | 3.68 | Mlig455_058555 | Neo: - Age: - |
SLC18A2 | 1.869 | - | - | - | 0.973 | 0.896 | - | Mlig455_058555 {REF} {Length: 2488} {Pfam: Major Facilitator Superfamily [PF07690.18, score=160.2]} {Human: ENSG00000165646, SLC18A2, solute carrier family 18 member A2, [RH, Score=505, Expect=4e-173]} {Mouse: ENSMUSG00000025094, Slc18a2, solute carrier family 18 (vesicular monoamine), member 2, [RH, Score=506, Expect=9e-174]} {Dmel: FBgn0260964, Vmat, Vesicular monoamine transporter, [RH, Score=522, Expect=9e-179]} {Celegans: WBGene00000295, cat-1, [RH, Score=478, Expect=1e-162]} {Smed: dd_Smed_v6_16043_0_1, dd_Smed_v6_16043_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_54526} {RNA1310_13917.1} {RNA815_24305} |
94. | MligTC455_15332 | 44 | 0.93 | Mlig455_062622, Mlig455_067527 | Neo: - Age: - Region-enriched R2: 7.516/0.00418 |
ASIC4 | 1.866 | - | - | - | 0.894 | 0.972 | - | Mlig455_062622 {REF} {Length: 2228} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=73.0]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=47.4, Expect=7e-06]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=51.6, Expect=2e-07]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=55.8, Expect=3e-09]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.1, Expect=2e-08]} {RNA1310_17847} {RNA815_27317} Mlig455_067527 {REF} {Length: 1916} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=147.3]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=50.1, Expect=1e-05]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=50.8, Expect=3e-06]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_19727_0_1, dd_Smed_v6_19727_0_1, [Score=53.5, Expect=2e-07]} {RNA1310_17847} {RNA815_27317} |
95. | MligTC455_26092 | 67 | 1.39 | Mlig455_048489 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.677 Region-enriched R2: 4.303/0.01110 |
1.866 | - | - | - | 0.979 | 0.887 | - | Mlig455_048489 {REF} {Length: 2319} {Pfam: Lectin C-type domain [PF00059.23, score=23.3]} {RNA1509_25383} {RNA1310_27113} {RNA815_24719} | |
96. | MligTC455_14257 | 69 | 1.45 | Mlig455_040352 | Neo: - Age: - |
1.865 | - | - | - | - | 0.883 | 0.982 | Mlig455_040352 {REF} {Length: 1357} {RNA1310_29786} {RNA815_30669} | |
97. | MligTC455_46885 | 72 | 1.49 | Mlig455_015138 | Neo: - Age: - |
PRKG2 | 1.864 | - | - | - | 0.891 | 0.973 | - | Mlig455_015138 {REF} {Length: 3064} {Pfam: Protein kinase domain [PF00069.27, score=227.4]; Cyclic nucleotide-binding domain [PF00027.31, score=128.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=118.5]; Kinase-like [PF14531.8, score=25.1]} {Human: ENSG00000138669, PRKG2, protein kinase cGMP-dependent 2, [RH, Score=674, Expect=0.0]} {Mouse: ENSMUSG00000029334, Prkg2, protein kinase, cGMP-dependent, type II, [RH, Score=674, Expect=0.0]} {Dmel: FBgn0000442, Pkg21D, Protein kinase, cGMP-dependent at 21D, [RH, Score=682, Expect=0.0]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=668, Expect=0.0]} {Smed: dd_Smed_v6_6967_0_1, dd_Smed_v6_6967_0_1, [RH, Score=676, Expect=0.0]} {RNA1509_26653} {RNA1310_15330.1} {RNA815_26005} |
98. | MligTC455_12085 | 11 | 0.22 | Mlig455_058618 | Neo: - Age: - |
NPFFR2 | 1.863 | - | - | - | 0.967 | 0.896 | - | Mlig455_058618 {REF} {Length: 1772} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=137.1]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.1]; Olfactory receptor [PF13853.8, score=20.7]} {Human: ENSG00000056291, NPFFR2, neuropeptide FF receptor 2, [Score=129, Expect=6e-32]} {Mouse: ENSMUSG00000028004, Npy2r, neuropeptide Y receptor Y2, [Score=127, Expect=5e-32]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=169, Expect=1e-46]} {Celegans: WBGene00016110, npr-11, Putative neuropeptide Y receptor 11, [Score=163, Expect=2e-45]} {Smed: dd_Smed_v6_16725_0_1, dd_Smed_v6_16725_0_1, [Score=248, Expect=3e-77]} |
99. | MligTC455_18583 | 12 | 0.24 | Mlig455_045246 | Neo: - Age: - |
1.859 | - | - | - | 0.879 | 0.980 | - | Mlig455_045246 {REF} {Length: 719} | |
100. | MligTC455_50410 | 31 | 0.64 | Mlig455_020239 | Neo: - Age: - |
GRIA2 | 1.857 | - | - | - | 0.879 | 0.978 | - | Mlig455_020239 {REF} {Length: 2096} {Pfam: Ligand-gated ion channel [PF00060.28, score=192.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=127.8]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=91.1]} {Human: ENSG00000120251, GRIA2, glutamate ionotropic receptor AMPA type subunit 2, [Score=513, Expect=7e-173]; ENSG00000152578, GRIA4, glutamate ionotropic receptor AMPA type subunit 4, [Score=496, Expect=3e-166]; ENSG00000155511, GRIA1, glutamate ionotropic receptor AMPA type subunit 1, [Score=494, Expect=8e-167]; ENSG00000125675, GRIA3, glutamate ionotropic receptor AMPA type subunit 3, [Score=491, Expect=1e-164]} {Mouse: ENSMUSG00000033981, Gria2, glutamate receptor, ionotropic, AMPA2 (alpha 2), [Score=507, Expect=4e-171]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=497, Expect=4e-167]; ENSMUSG00000020524, Gria1, glutamate receptor, ionotropic, AMPA1 (alpha 1), [Score=494, Expect=1e-165]; ENSMUSG00000001986, Gria3, glutamate receptor, ionotropic, AMPA3 (alpha 3), [Score=491, Expect=1e-164]} {Dmel: FBgn0038837, CG3822, [Score=432, Expect=1e-142]} {Celegans: WBGene00001612, glr-1, Glutamate receptor 1, [Score=459, Expect=5e-152]} {Smed: dd_Smed_v6_7562_0_1, dd_Smed_v6_7562_0_1, [Score=528, Expect=2e-179]} {RNA1509_56139} {RNA1310_38868} {RNA815_32684} |